EdenteV2, PascalFrancis, Corpus, bibRecord, 000437

Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes

Identifieur interne : 000437 ( PascalFrancis/Corpus ); précédent : 000436; suivant : 000438

Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes

Auteurs : Wendy A. Shultis ; E. Jennifer Weil ; Helen C. Looker ; Jeffrey M. Curtis ; Marc Shlossman ; Robert J. Genco ; William C. Knowler ; Robert G. Nelson

Source :

Diabetes care [ 0149-5992 ] ; 2007.

RBID : Pascal:07-0230055

Descripteurs français

Pascal (Inist)
- Parodontite, Homme, Néphropathie, Insuffisance rénale, Diabète type 2.

English descriptors

KwdEn :
- Human, Nephropathy, Periodontitis, Renal failure, Type 2 diabetes.

Abstract

OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m², and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0149-5992`
A02	`01`			`@0 DICAD2`
A03		`1`		`@0 Diabetes care`
A05				`@2 30`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes`
A11	`01`	`1`		`@1 SHULTIS (Wendy A.)`
A11	`02`	`1`		`@1 WEIL (E. Jennifer)`
A11	`03`	`1`		`@1 LOOKER (Helen C.)`
A11	`04`	`1`		`@1 CURTIS (Jeffrey M.)`
A11	`05`	`1`		`@1 SHLOSSMAN (Marc)`
A11	`06`	`1`		`@1 GENCO (Robert J.)`
A11	`07`	`1`		`@1 KNOWLER (William C.)`
A11	`08`	`1`		`@1 NELSON (Robert G.)`
A14	`01`			`@1 Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health @2 Phoenix, Arizona @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 7 aut. @Z 8 aut.`
A14	`02`			`@1 Department of Oral Biology, State University of New York at Buffalo @2 Buffalo, New York @3 USA @Z 5 aut. @Z 6 aut.`
A14	`03`			`@1 Arizona School of Dentistry and Oral Health @2 Mesa, Arizona @3 USA @Z 5 aut.`
A20				`@1 306-311`
A21				`@1 2007`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 18054 @5 354000143320930180`
A44				`@0 0000 @1 © 2007 INIST-CNRS. All rights reserved.`
A45				`@0 37 ref.`
A47	`01`	`1`		`@0 07-0230055`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Diabetes care`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m², and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.
C02	`01`	`X`		`@0 002B21E01A`
C02	`02`	`X`		`@0 002B10C02`
C03	`01`	`X`	`FRE`	`@0 Parodontite @5 01`
C03	`01`	`X`	`ENG`	`@0 Periodontitis @5 01`
C03	`01`	`X`	`SPA`	`@0 Parodontitis @5 01`
C03	`02`	`X`	`FRE`	`@0 Homme @5 02`
C03	`02`	`X`	`ENG`	`@0 Human @5 02`
C03	`02`	`X`	`SPA`	`@0 Hombre @5 02`
C03	`03`	`X`	`FRE`	`@0 Néphropathie @5 04`
C03	`03`	`X`	`ENG`	`@0 Nephropathy @5 04`
C03	`03`	`X`	`SPA`	`@0 Nefropatía @5 04`
C03	`04`	`X`	`FRE`	`@0 Insuffisance rénale @5 07`
C03	`04`	`X`	`ENG`	`@0 Renal failure @5 07`
C03	`04`	`X`	`SPA`	`@0 Insuficiencia renal @5 07`
C03	`05`	`X`	`FRE`	`@0 Diabète type 2 @2 NM @5 10`
C03	`05`	`X`	`ENG`	`@0 Type 2 diabetes @2 NM @5 10`
C03	`05`	`X`	`SPA`	`@0 Diabetes de tipo 2 @2 NM @5 10`
C07	`01`	`X`	`FRE`	`@0 Stomatologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Stomatology @5 37`
C07	`01`	`X`	`SPA`	`@0 Estomatología @5 37`
C07	`02`	`X`	`FRE`	`@0 Parodontopathie @5 38`
C07	`02`	`X`	`ENG`	`@0 Periodontal disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Parodontopatía @5 38`
C07	`03`	`X`	`FRE`	`@0 Appareil urinaire pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Urinary system disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Aparato urinario patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Rein pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Kidney disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Riñón patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Endocrinopathie @5 41`
C07	`05`	`X`	`ENG`	`@0 Endocrinopathy @5 41`
C07	`05`	`X`	`SPA`	`@0 Endocrinopatía @5 41`
C07	`06`	`X`	`FRE`	`@0 Métabolisme pathologie @5 42`
C07	`06`	`X`	`ENG`	`@0 Metabolic diseases @5 42`
C07	`06`	`X`	`SPA`	`@0 Metabolismo patología @5 42`
N21				`@1 155`

Format Inist (serveur)

NO :	PASCAL 07-0230055 INIST
ET :	Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes
AU :	SHULTIS (Wendy A.); WEIL (E. Jennifer); LOOKER (Helen C.); CURTIS (Jeffrey M.); SHLOSSMAN (Marc); GENCO (Robert J.); KNOWLER (William C.); NELSON (Robert G.)
AF :	Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health/Phoenix, Arizona/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 7 aut., 8 aut.); Department of Oral Biology, State University of New York at Buffalo/Buffalo, New York/Etats-Unis (5 aut., 6 aut.); Arizona School of Dentistry and Oral Health/Mesa, Arizona/Etats-Unis (5 aut.)
DT :	Publication en série; Niveau analytique
SO :	Diabetes care; ISSN 0149-5992; Coden DICAD2; Etats-Unis; Da. 2007; Vol. 30; No. 2; Pp. 306-311; Bibl. 37 ref.
LA :	Anglais
EA :	OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m², and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.
CC :	002B21E01A; 002B10C02
FD :	Parodontite; Homme; Néphropathie; Insuffisance rénale; Diabète type 2
FG :	Stomatologie; Parodontopathie; Appareil urinaire pathologie; Rein pathologie; Endocrinopathie; Métabolisme pathologie
ED :	Periodontitis; Human; Nephropathy; Renal failure; Type 2 diabetes
EG :	Stomatology; Periodontal disease; Urinary system disease; Kidney disease; Endocrinopathy; Metabolic diseases
SD :	Parodontitis; Hombre; Nefropatía; Insuficiencia renal; Diabetes de tipo 2
LO :	INIST-18054.354000143320930180
ID :	07-0230055

Links to Exploration step

Pascal:07-0230055

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes</title>
<author><name sortKey="Shultis, Wendy A" sort="Shultis, Wendy A" uniqKey="Shultis W" first="Wendy A." last="Shultis">Wendy A. Shultis</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Weil, E Jennifer" sort="Weil, E Jennifer" uniqKey="Weil E" first="E. Jennifer" last="Weil">E. Jennifer Weil</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Looker, Helen C" sort="Looker, Helen C" uniqKey="Looker H" first="Helen C." last="Looker">Helen C. Looker</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Curtis, Jeffrey M" sort="Curtis, Jeffrey M" uniqKey="Curtis J" first="Jeffrey M." last="Curtis">Jeffrey M. Curtis</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shlossman, Marc" sort="Shlossman, Marc" uniqKey="Shlossman M" first="Marc" last="Shlossman">Marc Shlossman</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Arizona School of Dentistry and Oral Health</s1>
<s2>Mesa, Arizona</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Genco, Robert J" sort="Genco, Robert J" uniqKey="Genco R" first="Robert J." last="Genco">Robert J. Genco</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Knowler, William C" sort="Knowler, William C" uniqKey="Knowler W" first="William C." last="Knowler">William C. Knowler</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nelson, Robert G" sort="Nelson, Robert G" uniqKey="Nelson R" first="Robert G." last="Nelson">Robert G. Nelson</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0230055</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0230055 INIST</idno>
<idno type="RBID">Pascal:07-0230055</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000437</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes</title>
<author><name sortKey="Shultis, Wendy A" sort="Shultis, Wendy A" uniqKey="Shultis W" first="Wendy A." last="Shultis">Wendy A. Shultis</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Weil, E Jennifer" sort="Weil, E Jennifer" uniqKey="Weil E" first="E. Jennifer" last="Weil">E. Jennifer Weil</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Looker, Helen C" sort="Looker, Helen C" uniqKey="Looker H" first="Helen C." last="Looker">Helen C. Looker</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Curtis, Jeffrey M" sort="Curtis, Jeffrey M" uniqKey="Curtis J" first="Jeffrey M." last="Curtis">Jeffrey M. Curtis</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shlossman, Marc" sort="Shlossman, Marc" uniqKey="Shlossman M" first="Marc" last="Shlossman">Marc Shlossman</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Arizona School of Dentistry and Oral Health</s1>
<s2>Mesa, Arizona</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Genco, Robert J" sort="Genco, Robert J" uniqKey="Genco R" first="Robert J." last="Genco">Robert J. Genco</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Knowler, William C" sort="Knowler, William C" uniqKey="Knowler W" first="William C." last="Knowler">William C. Knowler</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nelson, Robert G" sort="Nelson, Robert G" uniqKey="Nelson R" first="Robert G." last="Nelson">Robert G. Nelson</name>
<affiliation><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Diabetes care</title>
<title level="j" type="abbreviated">Diabetes care</title>
<idno type="ISSN">0149-5992</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Diabetes care</title>
<title level="j" type="abbreviated">Diabetes care</title>
<idno type="ISSN">0149-5992</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Human</term>
<term>Nephropathy</term>
<term>Periodontitis</term>
<term>Renal failure</term>
<term>Type 2 diabetes</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parodontite</term>
<term>Homme</term>
<term>Néphropathie</term>
<term>Insuffisance rénale</term>
<term>Diabète type 2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m<sup>2</sup>
, and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0149-5992</s0>
</fA01>
<fA02 i1="01"><s0>DICAD2</s0>
</fA02>
<fA03 i2="1"><s0>Diabetes care</s0>
</fA03>
<fA05><s2>30</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SHULTIS (Wendy A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>WEIL (E. Jennifer)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>LOOKER (Helen C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>CURTIS (Jeffrey M.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SHLOSSMAN (Marc)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GENCO (Robert J.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KNOWLER (William C.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>NELSON (Robert G.)</s1>
</fA11>
<fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Arizona School of Dentistry and Oral Health</s1>
<s2>Mesa, Arizona</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>306-311</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18054</s2>
<s5>354000143320930180</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>37 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0230055</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Diabetes care</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m<sup>2</sup>
, and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B21E01A</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B10C02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parodontite</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Periodontitis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parodontitis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Néphropathie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nephropathy</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Nefropatía</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Insuffisance rénale</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Renal failure</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Insuficiencia renal</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Diabète type 2</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Type 2 diabetes</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Diabetes de tipo 2</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Stomatologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Stomatology</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Estomatología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Parodontopathie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Periodontal disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Parodontopatía</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Appareil urinaire pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Urinary system disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Aparato urinario patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Rein pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Kidney disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Riñón patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Endocrinopathie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Endocrinopathy</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Endocrinopatía</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Métabolisme pathologie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Metabolic diseases</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Metabolismo patología</s0>
<s5>42</s5>
</fC07>
<fN21><s1>155</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 07-0230055 INIST</NO>
<ET>Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes</ET>
<AU>SHULTIS (Wendy A.); WEIL (E. Jennifer); LOOKER (Helen C.); CURTIS (Jeffrey M.); SHLOSSMAN (Marc); GENCO (Robert J.); KNOWLER (William C.); NELSON (Robert G.)</AU>
<AF>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health/Phoenix, Arizona/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 7 aut., 8 aut.); Department of Oral Biology, State University of New York at Buffalo/Buffalo, New York/Etats-Unis (5 aut., 6 aut.); Arizona School of Dentistry and Oral Health/Mesa, Arizona/Etats-Unis (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Diabetes care; ISSN 0149-5992; Coden DICAD2; Etats-Unis; Da. 2007; Vol. 30; No. 2; Pp. 306-311; Bibl. 37 ref.</SO>
<LA>Anglais</LA>
<EA>OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m<sup>2</sup>
, and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.</EA>
<CC>002B21E01A; 002B10C02</CC>
<FD>Parodontite; Homme; Néphropathie; Insuffisance rénale; Diabète type 2</FD>
<FG>Stomatologie; Parodontopathie; Appareil urinaire pathologie; Rein pathologie; Endocrinopathie; Métabolisme pathologie</FG>
<ED>Periodontitis; Human; Nephropathy; Renal failure; Type 2 diabetes</ED>
<EG>Stomatology; Periodontal disease; Urinary system disease; Kidney disease; Endocrinopathy; Metabolic diseases</EG>
<SD>Parodontitis; Hombre; Nefropatía; Insuficiencia renal; Diabetes de tipo 2</SD>
<LO>INIST-18054.354000143320930180</LO>
<ID>07-0230055</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000437 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000437 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:07-0230055
   |texte=   Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes
}}

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022

	Serveur d'exploration sur le patient édenté
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le patient édenté

Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes

Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri